Back to top
more

Sabra Healthcare REIT (SBRA)

(Real Time Quote from BATS)

$13.70 USD

13.70
338,448

0.00 (0.00%)

Updated Apr 25, 2024 11:22 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value F Growth A Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 41% (147 out of 251)

Industry: REIT and Equity Trust - Other

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Washington Prime Makes Leasing Progress a Southern Park Mall

by Zacks Equity Research

Redevelopment efforts at Southern Park Mall have likely enabled Washington Prime (WPG) to retain its existing tenants at the site and introduce new ones even in these uncertain times.

Should You Hold Ventas (VTR) Stock in Your Portfolio Now?

by Zacks Equity Research

Ventas (VTR) is focusing to capture the upside in the office segment amid higher demand for research and innovation space. Yet, choppy fundamental of the senior housing market is a spoilsport.

Sabra Healthcare (SBRA) Q2 FFO and Revenues Beat Estimates

by Zacks Equity Research

Sabra (SBRA) delivered FFO and revenue surprises of 12.50% and 5.24%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Sabra Healthcare (SBRA) Tops Q1 FFO Estimates

by Zacks Equity Research

Sabra (SBRA) delivered FFO and revenue surprises of 2.27% and -3.20%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Company News for Feb 25, 2020

by Zacks Equity Research

Companies In The News Are: SBRA, CTB, DORM, CRI.

Sabra Healthcare (SBRA) Surpasses Q4 FFO and Revenue Estimates

by Zacks Equity Research

Sabra (SBRA) delivered FFO and revenue surprises of 4.44% and 3.52%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Sabra Healthcare (SBRA) Surpasses Q3 FFO Estimates

by Zacks Equity Research

Sabra (SBRA) delivered FFO and revenue surprises of 2.17% and -2.32%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Sabra (SBRA) Amends $2.2B Credit Facility, Extends Maturities

by Zacks Equity Research

Sabra Health Care (SBRA) restates unsecured credit facility aggregating $2.2 billion, which will improve its debt maturities laddering. The company has no significant expirations until 2022.

Sabra Healthcare (SBRA) Q2 FFO Miss Estimates

by Zacks Equity Research

Sabra (SBRA) delivered FFO and revenue surprises of -2.13% and 35.27%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Sabra Healthcare (SBRA) Lags Q1 FFO and Revenue Estimates

by Zacks Equity Research

Sabra (SBRA) delivered FFO and revenue surprises of -4.00% and -5.59%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Iron Mountain (IRM) to Report Q4 Earnings: What to Expect?

by Zacks Equity Research

Iron Mountain (IRM) expected to report a decline in storage rental revenues from the North American data-management segment owing to moderating volumes.

Key Factors to Impact Arbor Realty's (ABR) Q4 Earnings

by Zacks Equity Research

High levels of loan originations will support Arbor Realty's (ABR) performance in the fourth quarter. However, stiff competition in the lending market might have resulted in aggressive pricing.

What's in Store for Regency Centers (REG) in Q4 Earnings?

by Zacks Equity Research

Regency Centers (REG) will gain from premium grocery-anchored shopping centers, and focus on necessity, value, convenience and service oriented retailers will guard it from e-commerce slaughter in Q4.

Can Federal Realty (FRT) Pull Off a Surprise in Q4 Earnings?

by Zacks Equity Research

Federal Realty's (FRT) Q4 results to benefit from portfolio-repositioning efforts, upbeat consumer sales and improving absorption levels despite the choppy retail real estate environment.

What to Expect From Chimera (CIM) this Earnings Season?

by Zacks Equity Research

While Chimera Investment's (CIM) mortgage backed securities (MBS) portfolio is expected to support results, higher interest rates in Q4 will likely affect its book value.

Gaming and Leisure Properties (GLPI) Q4 Earnings Preview

by Zacks Equity Research

Gaming and Leisure Properties (GLPI) is expected to have generated stable cash flow from long-term triple-net master leases. Further, it will likely gain from strategic acquisitions.

What's in the Cards for Tanger (SKT) This Earnings Season?

by Zacks Equity Research

Despite Tanger Factory Outlet Centers' (SKT) focus on improving tenant mix, amenities and marketing programs, its Q4 results might be affected by store closures, bankruptcies and lease modifications.

Key Factors to Impact JLL's Performance This Earnings Season

by Zacks Equity Research

Jones Lang LaSalle's (JLL) Q4 results likely to reflect strength across its global regions and rising trend of outsourcing of real estate needs by companies.

CBRE Group (CBRE) to Post Q4 Earnings: What's in the Cards?

by Zacks Equity Research

CBRE Group (CBRE) will likely gain from improving occupier outsourcing business and strategic buyouts. Nonetheless, investors' cautious approach, trade tensions and political uncertainty remain woes.

Moving Average Crossover Alert: Sabra Healthcare

by Zacks Equity Research

Sabra Healthcare REIT, Inc. (SBRA) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.

Sabra Healthcare (SBRA) Misses Q3 FFO and Revenue Estimates

by Zacks Equity Research

Sabra (SBRA) delivered FFO and revenue surprises of -11.29% and -6.66%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

Alexandria Acquires 219 East 42nd Street, Boosts Portfolio

by Zacks Equity Research

Expanding its regional life-science cluster franchise in New York City, Alexandria Real Estate Equities (ARE) acquires a Manhattan office property through membership interest in 219/235 East LLC.

    Sabra Health Care Disposes Genesis & Signature Facilities

    by Zacks Equity Research

    Sabra Health Care (SBRA) to use proceeds from sale of nine Genesis Healthcare facilities, and another project leased to Signature Healthcare to reduce balance under its revolving credit facility.

      Aimco (AIV) to Report Q1 Earnings: Is a Beat in the Cards?

      by Zacks Equity Research

      Aimco's (AIV) Q1 results are likely to gain from elevated demand as a result of favorable demographics. Further, the company's diligent efforts to reposition its portfolio will help it perform better.

        Host Hotels (HST) to Report Q1 Earnings: What's in Store?

        by Zacks Equity Research

        Host Hotels & Resorts (HST) Q1 results likely to reflect benefits from its portfolio of upscale hotels across potential markets and productivity gains, and impact of high supply and tough comparisons.